Literature DB >> 31227916

Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study.

Samantha L Kingsley1, Douglas I Walker2, Antonia M Calafat3, Aimin Chen4, George D Papandonatos5, Yingying Xu6, Dean P Jones7, Bruce P Lanphear8,9, Kurt D Pennell10, Joseph M Braun11.   

Abstract

INTRODUCTION: Exposure to perfluoroalkyl substances (PFAS), synthetic and persistent chemicals used in commercial and industrial processes, are associated with cardiometabolic dysfunction and related risk factors including reduced birth weight, excess adiposity, and dyslipidemia. Identifying the metabolic changes induced by PFAS exposure could enhance our understanding of biological pathways underlying PFAS toxicity.
OBJECTIVE: To identify metabolic alterations associated with serum concentrations of four PFAS in children using a metabolome-wide association study.
METHODS: We performed untargeted metabolomic profiling by liquid chromatography with ultra-high-resolution mass spectrometry, and separately quantified serum concentrations of perfluorooctanoic acid, perfluorooctanesulfonic acid, perfluorononanoic acid, and perfluorohexanesulfonic acid (PFHxS) for 114 8-year old children from Cincinnati, OH. We evaluated associations between each serum PFAS concentration and 16,097 metabolic features using linear regression adjusted for child age, sex, and race with a false discovery rate < 20%. We annotated PFAS-associated metabolites and conducted pathway enrichment analyses.
RESULTS: Serum PFAS concentrations were associated with metabolic features annotated primarily as lipids and dietary factors. Biological pathways associated with all four PFAS included arginine, proline, aspartate, asparagine, and butanoate metabolism.
CONCLUSIONS: In this cross-sectional study, childhood serum PFAS concentrations were correlated with metabolic pathways related to energy production and catabolism. Future studies should determine whether these pathways mediate associations between PFAS exposure and childhood cardiometabolic health.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31227916      PMCID: PMC7172933          DOI: 10.1007/s11306-019-1560-z

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  60 in total

1.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

Review 2.  The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review.

Authors:  M H Park; C Falconer; R M Viner; S Kinra
Journal:  Obes Rev       Date:  2012-06-26       Impact factor: 9.213

3.  Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Authors:  Stephanie J Frisbee; Anoop Shankar; Sarah S Knox; Kyle Steenland; David A Savitz; Tony Fletcher; Alan M Ducatman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-09

Review 4.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.

Authors:  Marta Guasch-Ferré; Adela Hruby; Estefanía Toledo; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu
Journal:  Diabetes Care       Date:  2016-05       Impact factor: 19.112

5.  High-Resolution Metabolomics Assessment of Military Personnel: Evaluating Analytical Strategies for Chemical Detection.

Authors:  Ken H Liu; Douglas I Walker; Karan Uppal; ViLinh Tran; Patricia Rohrbeck; Timothy M Mallon; Dean P Jones
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

6.  Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI).

Authors:  Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant
Journal:  Metabolomics       Date:  2007-09       Impact factor: 4.290

7.  High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.

Authors:  Xiaobing Tan; Guoxiang Xie; Xiuhua Sun; Qiong Li; Wei Zhong; Peter Qiao; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.

Authors:  Abby F Fleisch; Sheryl L Rifas-Shiman; Ana M Mora; Antonia M Calafat; Xiaoyun Ye; Heike Luttmann-Gibson; Matthew W Gillman; Emily Oken; Sharon K Sagiv
Journal:  Environ Health Perspect       Date:  2016-09-02       Impact factor: 9.031

9.  Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.

Authors:  Tanya L Alderete; Ran Jin; Douglas I Walker; Damaskini Valvi; Zhanghua Chen; Dean P Jones; Cheng Peng; Frank D Gilliland; Kiros Berhane; David V Conti; Michael I Goran; Lida Chatzi
Journal:  Environ Int       Date:  2019-03-04       Impact factor: 9.621

10.  LIPID MAPS online tools for lipid research.

Authors:  Eoin Fahy; Manish Sud; Dawn Cotter; Shankar Subramaniam
Journal:  Nucleic Acids Res       Date:  2007-06-21       Impact factor: 16.971

View more
  18 in total

Review 1.  Non-targeted metabolomics and associations with per- and polyfluoroalkyl substances (PFAS) exposure in humans: A scoping review.

Authors:  Pengfei Guo; Tristan Furnary; Vasilis Vasiliou; Qi Yan; Kate Nyhan; Dean P Jones; Caroline H Johnson; Zeyan Liew
Journal:  Environ Int       Date:  2022-02-26       Impact factor: 9.621

2.  Comparison of untargeted and targeted perfluoroalkyl acids measured in adolescent girls.

Authors:  Lauren M Petrick; Mary S Wolff; Dinesh Barupal; Susan L Teitelbaum
Journal:  Chemosphere       Date:  2021-12-15       Impact factor: 7.086

3.  Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.

Authors:  Che-Jung Chang; Dana Boyd Barr; P Barry Ryan; Parinya Panuwet; Melissa M Smarr; Ken Liu; Kurunthachalam Kannan; Volha Yakimavets; Youran Tan; ViLinh Ly; Carmen J Marsit; Dean P Jones; Elizabeth J Corwin; Anne L Dunlop; Donghai Liang
Journal:  Environ Int       Date:  2021-11-01       Impact factor: 9.621

4.  Infant Metabolome in Relation to Prenatal DHA Supplementation and Maternal Single-Nucleotide Polymorphism rs174602: Secondary Analysis of a Randomized Controlled Trial in Mexico.

Authors:  Sonia Tandon; Ines Gonzalez-Casanova; Albino Barraza-Villarreal; Isabelle Romieu; Hans Demmelmair; Dean P Jones; Berthold Koletzko; Aryeh D Stein; Usha Ramakrishnan
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.687

Review 5.  Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer.

Authors:  Raya I Boyd; Saeed Ahmad; Ratnakar Singh; Zeeshan Fazal; Gail S Prins; Zeynep Madak Erdogan; Joseph Irudayaraj; Michael J Spinella
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 6.  Obesity II: Establishing causal links between chemical exposures and obesity.

Authors:  Jerrold J Heindel; Sarah Howard; Keren Agay-Shay; Juan P Arrebola; Karine Audouze; Patrick J Babin; Robert Barouki; Amita Bansal; Etienne Blanc; Matthew C Cave; Saurabh Chatterjee; Nicolas Chevalier; Mahua Choudhury; David Collier; Lisa Connolly; Xavier Coumoul; Gabriella Garruti; Michael Gilbertson; Lori A Hoepner; Alison C Holloway; George Howell; Christopher D Kassotis; Mathew K Kay; Min Ji Kim; Dominique Lagadic-Gossmann; Sophie Langouet; Antoine Legrand; Zhuorui Li; Helene Le Mentec; Lars Lind; P Monica Lind; Robert H Lustig; Corinne Martin-Chouly; Vesna Munic Kos; Normand Podechard; Troy A Roepke; Robert M Sargis; Anne Starling; Craig R Tomlinson; Charbel Touma; Jan Vondracek; Frederick Vom Saal; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

7.  Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial.

Authors:  Susanna D Mitro; Jinxi Liu; Lindsay M Jaacks; Abby F Fleisch; Paige L Williams; William C Knowler; Blandine Laferrère; Wei Perng; George A Bray; Amisha Wallia; Marie-France Hivert; Emily Oken; Tamarra M James-Todd; Marinella Temprosa
Journal:  Int J Hyg Environ Health       Date:  2020-12-18       Impact factor: 5.840

8.  Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.

Authors:  Ran Jin; Rob McConnell; Cioffi Catherine; Shujing Xu; Douglas I Walker; Nikos Stratakis; Dean P Jones; Gary W Miller; Cheng Peng; David V Conti; Miriam B Vos; Leda Chatzi
Journal:  Environ Int       Date:  2019-11-16       Impact factor: 13.352

Review 9.  Application of metabolomics to characterize environmental pollutant toxicity and disease risks.

Authors:  Pan Deng; Xusheng Li; Michael C Petriello; Chunyan Wang; Andrew J Morris; Bernhard Hennig
Journal:  Rev Environ Health       Date:  2019-09-25       Impact factor: 4.022

Review 10.  Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Authors:  Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts
Journal:  Environ Toxicol Chem       Date:  2020-12-07       Impact factor: 4.218

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.